Skip to content

News & updates

Press Releases

MiRXES Welcomes Genomics Expert to Scientific Advisory Board

28 July, 2021

MiRXES Secures US$77 Million Series C Funding To Accelerate Multi-Cancer Early Detection Pipeline With Overwhelming Investor Support

8 July, 2021

MiRXES in 2000 participant multi-hospital study to detect liver cancer early

3 May, 2021

MSD Study Validates Performance of MiRXES qPCR Platform for microRNA Biomarker Development

11 March, 2021

A*STAR, TTSH and MiRXES launch multiplex COVID-19 kit that tests for SARS-CoV-2 and Influenza A and B

18 January, 2021

MiRXES and NUHS launch GASTROClear blood test for early detection of gastric cancer

23 October, 2020

Data from pulmonary hypertension collaboration with Janssen-J&J presented at ERS Congress 2020

8 September, 2020

Webinar: Launch of SS 656 Design, Development and Validation of miRNA-based Diagnostics (Video)

4 September, 2020

MiRXES launches Japan subsidiary

1 June, 2020
« Prev12Next »

Media Coverage

MiRXES ranked top 200 in FT/Nikkei Asia-Pacific High-Growth Companies 2021
31 March, 2021 / ,
Success Stories: MiRXES Japan
18 March, 2021 /
MiRXES test kit that can detect COVID-19 and seasonal flu gets HSA’s approval
18 January, 2021 /
COVID-19 and the coming of age of Singapore science
14 December, 2020 /
MiRXES Chief Scientific Advisor in SWITCH 2020 Video: 25 People, One Story (Video)
10 December, 2020 /
MiRXES CEO on SWITCH 2020 panel: Internationalisation of deep tech (Video)
9 December, 2020 /
MiRXES sets out to sell gastric cancer test across Asia
4 November, 2020 / ,
Channel News Asia report on GASTROClear (Video)
23 October, 2020 /
GASTROClear being evaluated for use in primary healthcare
23 October, 2020 /
« Prev1234Next »